TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 336 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,109 | -1.6% | 201 | 0.0% | 0.00% | – |
Q2 2023 | $3,158 | -4.6% | 201 | 0.0% | 0.00% | – |
Q1 2023 | $3,312 | +5.6% | 201 | 0.0% | 0.00% | – |
Q4 2022 | $3,136 | +4.5% | 201 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 201 | 0.0% | 0.00% | – |
Q3 2021 | $3,000 | 0.0% | 201 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | -25.0% | 201 | 0.0% | 0.00% | – |
Q1 2021 | $4,000 | 0.0% | 201 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | 0.0% | 201 | 0.0% | 0.00% | – |
Q3 2020 | $4,000 | 0.0% | 201 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $4,000 | +33.3% | 201 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | -25.0% | 201 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | +33.3% | 201 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | -25.0% | 201 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $4,000 | – | 201 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |